Psychotherapy for obsessive-compulsive disorder

Current Psychiatry Reports

Volumn 11, Issue 4, 2009, Pages 296-301

  Storch, Eric A ^a   Mariaskin, Amy ^b   Murphy, Tanya K ^b  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSERINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

BEHAVIOR CONTROL; CHILD PSYCHIATRY; CLINICAL EFFECTIVENESS; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DRUG DOSE COMPARISON; FAMILY THERAPY; HUMAN; OBSESSIVE COMPULSIVE DISORDER; PHOBIA; QUALITY OF LIFE; REINFORCEMENT; RELAXATION TRAINING; REVIEW; SOCIAL PHOBIA; STATE DEPENDENT LEARNING; STRESS MANAGEMENT; TELEPSYCHIATRY; TREATMENT RESPONSE;

ADULT; CHILD; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; CONTROLLED CLINICAL TRIALS AS TOPIC; CYCLOSERINE; DESENSITIZATION, PSYCHOLOGIC; EMPIRICAL RESEARCH; HUMANS; OBSESSIVE-COMPULSIVE DISORDER; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOTHERAPY, GROUP; SEROTONIN AGENTS; THERAPY, COMPUTER-ASSISTED; TREATMENT OUTCOME;

EID: 67849127014     PISSN: 15233812     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11920-009-0043-8     Document Type: Review

References (54)

1. Abramowitz JS, Whiteside SP, Deacon BJ: The effectiveness of treatment for pediatric obsessive-compulsive disorder. Behav Ther 2005, 36:55-63.
2. Pediatric OCD Treatment Study (POTS) Team: Cognitivebehavior therapy, sertraline, and their combination for children and adolescents with obsessive-compulsive disorder: The Pediatric OCD Treatment Study (POTS) randomized controlled trial. JAMA 2004, 292:1969-1976.
3. Foa EB, Liebowitz MR, Kozak MJ, et al.: Randomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder. Am J Psychiatry 2005, 162:151-161.
4. Barlow DH: Anxiety and its Disorders. New York: Guilford Press; 1988.
5. Clark DM: A cognitive approach to panic. Behav Res Ther 1986, 24:461-470.
6. Rapee RM, Heimberg RG: A cognitive-behavioral model of anxiety in social phobia. Behav Res Ther 1997, 35:741-756.
7. Foa EB, Kozak MJ: TreatmenI of anxiety disorders: implications for psychopathology. In Anxiety and the Anxiety Disorders. Edited by Tuma AH, Maser JD. Mahwah, NJ: Lawrence Erlbaum Associates; 1985:421-452.
8. Salkovskis PM: Obsessional-Aompulsive problems: a cognitivebehavioural analysis. Behav Res Ther 1985, 23:571-583.
9. March JS, Franklin M, Nelson A, Foa E: Cognitive-behavioral psychotherapy for pediatric obsessive-compulsive disorder. J Clin Child Psychol 2001, 30:8-18.
10. Barrett PD, Farrell L, Pina AA, et al.: Evidence-based psychosocial treatments for child and adolescent obsessive-compulsive disorder. J Clin Child Adolesc Psychol 2008, 37:131-155.
11. Franklin ME, Foa EB: Cognitive-behavioral treatments for obsessive-compulsive disorder. In A Guide to Treatments That Work. Edited by Nathan PE, Gorman JM. London: Oxford University Press; 2002:367-386.
12. American Academy of Child and Adolescent Psychiatry (AACAP): Practice parameters for the assessment and treatment of children and adolescents with obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 1998, 37:527-545.
13. Foa EB, Kozak MJ: Psychological treatments for obsessivecompulsive disorder. In Long-term Treatments of Anxiety Disorders. Edited by Mavissakalian MR, Prien RF. Washington, DC: American Psychiatric Association; 1996:285-309.
14. Franklin ME, Abramowitz JS, Kozak MJ, et al.: Effectiveness of exposure and ritual prevention for obsessive-compulsive disorder: Randomized compared with nonrandomized samples. J Consult Clin Psychol 2000, 68:594-602.
15. Black DW: Efficacy of combined pharmacotherapy and psychotherapy versus monotherapy in the treatment of anxiety disorders. CNS Spect 2006, 11(10 Suppl 12):29-33.
16. March JS, Benton CM: Talking Back to OCD: The Program That Helps Kids and Teens Say "No Way" and Parents Say "Way to Go." New York: Guilford Press; 2007.
17. Valderhaug R, Larsson B, Gotestam KG, Piacentini J: An open clinical trial of cognitive-behaviour therapy in children and adolescents with obsessive-compulsive disorder administered in regular outpatient clinics. Behav Res Ther 2007, 45:577-589.
18. Abramowitz JS, Foa EB, Franklin ME: Exposure and ritual prevention for obsessive-compulsive disorder: Effectiveness of intensive versus twice-weekly treatment sessions. J Consult Clin Psychol 2003, 71:394-398.
19. Franklin ME, Kozak MJ, Cashman LA, et al.: Cognitivebehavioral treatment of pediatric obsessive-compulsive disorder: An open clinical trial. J Am Acad Child Adolesc Psychiatry 1998, 37:412-419.
20. Storch EA, Geffken GR, Merlo LJ, et al.: Family-based cognitive-therapy for pediatric obsessive-compulsive disorder: Comparison of intensive and weekly approaches. J Am Acad Child Adolesc Psychiatry 2007, 46:469-478.
21. Foa EB, Franklin ME, Kozak MJ: Psychosocial treatment of obsessive-compulsive disorder: Literature review. In Obsessive-Compulsive Disorder: Theory, Research, and Treatment. Edited by Swinson RP, Antony MM, Rachman S, Richter MA. New York: Guilford Press; 1998:258-276.
22. Salkovskis PM, Forrester E, Richards C: Cognitivebehavioural approach to understanding obsessional thinking. Br J Psychiatry 1998, 173:53-66.
23. Krochmalik A, Jones MK, Menzies RG: Danger ideation reduction therapy (DIRT) for treatment-resistant compulsive washing. Behav Res Ther 2001, 39:897-912.
24. van Oppen P, de Haan E, van Balkom A, et al.: Cognitive therapy and exposure in vivo in the treatment of obsessive compulsive disorder. Behav Res Ther 1995, 33:379-390.
25. Wilhelm S, Steketee G, Reilly-Harrington NA, et al.: Effectiveness of cognitive therapy for obsessive-compulsive disorder: An open trial. J Cogn Psychother 2005, 19:173-179.
26. Wilson KA, Chambless DL: Cognitive therapy for obsessivecompulsive disorder. Behav Res Ther 2005, 43:1645-1654.
27. Freeman JB, GarPia AM, Coyne L, et al.: Early childhood OCD: preliminary findings from a family-based cognitive-behavioral approach. J Am Acad Child Adolesc Psychiatry 2008, 47:593-602.
28. Barrett P, Healy-Farrell L, March JS: Cognitive-behavioral treatment of childhood obsessive-compulsive disorder: A controlled trial. J Am Acad Child Adolesc Psychiatry 2004, 43:46-62.
29. Whiteside SP, Brown AM, Abramowitz JS: Five-day intensive treatment for adolescent OCD: A case series. J Anxiety Disord 2008, 22:495-504.
30. Rowa K, Antony MM, Summerfeldt LJ, et al.: Office-based vs. home-based behavioral treatment for obsessive-compulsive disorder: A preliminary study. Behav Res Ther 2007, 45:1883-1892.
31. Tolin DF, Hannan S, Maltby N, et al.: A randomized controlled trial of self-directed versus therapist-directed cognitive-behavioral therapy for obsessive-compulsive disorder patients with prior medication trials. Behav Ther 2007, 38:179-191.
32. Anderson RA, Rees CS: Group versus individual cognitivebehavioural treatment for obsessive-compulsive disorder: A controlled trial. Behav Res Ther 2007, 45:123-137.
33. Ginsberg GS, Kingery JN, Drake KL, Grados MA: Predictors of treatment response in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2008, 47:868-878.
34. Storch EA, Merlo LJ, Larson MJ, et al.: Impact of comorbidity on cognitive-behavioral therapy response in pediatric obsessive-compulsive disorder. J Am Acad Child Adolesc Psychiatry 2008, 47:583-592.
35. Hansen B, Vogel PA, Stiles TC, Götestam KG: Influence of co-morbid generalized anxiety disorder, panic disorder and personality disorders on the outcome of cognitive behavioural treatment of obsessive-compulsive disorder. Cogn Behav Ther 2007, 36:145-155.
36. Storch EA, Merlo LJ, Larson MJ, et al.: Symptom dimensions and cognitive-behavioural therapy outcome for pediatric obsessive-compulsive disorder. Acta Psychiatr Scand 2008, 117:67-75.
37. Diefenbach GJ, Abramowitz JS, Norberg MM, Tolin DF: Changes in quality of life following cognitive-behavioral therapy for obsessive-compulsive disorder. Behav Res Ther 2007, 45:3060-3068.
38. Storch EA, Murphy TK, Lack CW, et al.: Sleep-related problems in pediatric obsessive-compulsive disorder. J Anxiety Disord 2008, 22:877-885.
39. Walker DL, Ressler KJ, Lu KT, Davis M: Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats. J Neurosci 2002, 22:2343-2351.
40. Ledgerwood L, Richardson R, Cranney J: Effects of D-cycloserine on extinction of conditioned freezing. Behav Neurosci 2003, 117:341-349.
41. Ledgerwood L, Richardson R, Cranney J: D-cycloserine and the facilitation of extinction of conditioned fear: Consequences for reinstatement. Behav Neurosci 2004, 118:505-513.
42. Ledgerwood L, Richardson R, Cranney J: D-cycloserine facilitates extinction of learned fear: Effects on reacquisition and generalized extinction. Biol Psychiatry 2005, 57:841-847.
43. Ressler KJ, Rothbaum BO, Tannenbaum L, et al.: Cognitive enhancers as adjuncts to psychotherapy: Use of D-cycloserine in phobic individuals to facilitate extinction of fear. Arch Gen Psychiatry 2004, 61:1136-1144.
44. Hofmann SG, Pollack MH, Otto MW: Augmentation treatment of psychotherapy for anxiety disorders with D-cycloserine. CNS Drug Rev 2006, 12:208-217.
45. Wilhelm S, Buhlmann U, Tolin DF, et al.: Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder. Am J Psychiatry 2008, 165:335-341.
46. Kushner MG, Kim SW, Donahue C, et al.: D-cycloserine augmented exposure therapy for obsessive-compulsive disorder. Biol Psychiatry 2007, 62:835-838.
47. Storch EA, Merlo LJ, Bengtson M, et al.: D-cycloserine does not enhance exposure-response prevention therapy in obsessive-compulsive disorder. Int Clin Psychopharmacol 2007, 22:230-237.
48. Simpson HB, Foa EB, Liebowitz MR, et al.: A randomized, controlled trial of cognitive-behavioral therapy for augmenting pharmacotherapy in obsessive-compulsive disorder. Am J Psychiatry 2008, 165:621-630.
49. Simpson HB, Zuckoff A, Page JR, et al.: Adding motivational interviewing to exposure and ritual prevention for obsessive-compulsive disorder: An open pilot trial. Cogn Behav Ther 2008, 37:38-49.
50. Tolin DF, Maltby N, Diefenbach GJ, et al.: Cognitivebehavioral therapy for medication nonresponders with obsessive-compulsive disorder: A wait-list-controlled open trial. J Clin Psychiatry 2004, 65:922-931.
51. Fritzler BK, Hecker JE, Losee MC: Self-directed treatment with minimal therapist contact: Preliminary findings for obsessive-compulsive disorder. Behav Res Ther 1997, 35:627-631.
52. Tolin DF, Diefenbach GJ, Maltby N, Hannan SE: Stepped care for obsessive-compulsive disorder: A pilot study. Cogn Behav Pract 2005, 12:403-414.
53. Greist JH, Marks IM, Baer L, et al.: Behavior therapy for obsessive-compulsive disorder guided by a computer or by a clinician compared with relaxation as a control. J Clin Psychiatry 2002, 63:138-145.
54. Tolin DF, Hannan S, Maltby N, et al.: A randomized controlled trial of self-directed versus therapist-directed cognitive-behavioral therapy for obsessive-compulsive disorder patients with prior medication trials. Behav Ther 2007, 38:179-191.